These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10518231)

  • 81. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations.
    Belsey EM; Peregoudov S
    Contraception; 1988 Aug; 38(2):227-42. PubMed ID: 2971507
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
    Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
    Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Millions of couples to have choice of injectable contraceptive.
    Integration; 1996; (47):41. PubMed ID: 12347310
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Serum copper and zinc in hormonal contraceptive users.
    Prema K; Ramalakshmi BA; Babu S
    Fertil Steril; 1980 Mar; 33(3):267-71. PubMed ID: 6444895
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pituitary response to LHRH in long-term users of injectable contraceptives.
    Ismail AA; el-Faras A; Rocca M; el-Sibai FA; Toppozada M
    Contraception; 1987 May; 35(5):487-95. PubMed ID: 2957167
    [TBL] [Abstract][Full Text] [Related]  

  • 86. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F; Lehnert J; Lachnit U
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Community-based distribution of injectable contraceptives in an African setting: community trial in Madagascar].
    Brunie A; Hoke TH; Razafindravony B
    Sante; 2011; 21(1):21-6. PubMed ID: 21550921
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Assessing the acceptability of NORPLANT implants in four countries: findings from focus group research.
    Zimmerman M; Haffey J; Crane E; Szumowski D; Alvarez F; Bhiromrut P; Brache V; Lubis F; Salah M; Shaaban M
    Stud Fam Plann; 1990; 21(2):92-103. PubMed ID: 2112794
    [TBL] [Abstract][Full Text] [Related]  

  • 90. One-month injectables are popular choice in Mexico.
    Netw Res Triangle Park N C; 1984; 5(3):4-5. PubMed ID: 12279798
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
    Amatayakul K; Petpoo W; Ratanawananukul N; Tanthayaphinant O; Tovanabutra S; Suriyanon V
    Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Femiject, a once-a-month combined injectable contraceptive: experience from Pakistan.
    Izhar R; Husain S; Tahir MA; Husain S
    Eur J Contracept Reprod Health Care; 2020 Oct; 25(5):359-364. PubMed ID: 32757796
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Endometrial histology in long-term users of the once-a-month injectable contraceptive Cyclofem.
    Bahamondes L; Maradiegue E; Diaz J; Trelles J; Escanhoela C; Petta C; Arce XE
    Adv Contracept; 1999; 15(1):1-7. PubMed ID: 10794041
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Next step for Egypt -- access to more methods.
    Herndon N
    Netw Res Triangle Park N C; 1993 Mar; 13(3):18-21. PubMed ID: 12318096
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations.
    Aedo AR; Landgren BM; Johannisson E; Diczfalusy E
    Contraception; 1985 May; 31(5):453-69. PubMed ID: 4028723
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
    Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005214. PubMed ID: 16856087
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The introduction of Cyclofem into national family planning programmes: experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia. Task Force on Research on Introduction and Transfer of Technologies for Fertility Regulation, Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.
    Hall PE
    Contraception; 1994 May; 49(5):489-507. PubMed ID: 8045134
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
    Andino N
    Contraception; 1981 Feb; 23(2):141-55. PubMed ID: 6786825
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Managing menstrual disturbances.
    Barnett B
    Netw Res Triangle Park N C; 1995 Jun; 15(4):8. PubMed ID: 12289833
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Injectable and implantable contraceptives.
    Cullins VE
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):536-43. PubMed ID: 1387011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.